Multidisciplinary approach to managing GPRC5D-related adverse events in relapsed or refractory multiple myeloma patients. - Albrecht N; Boeckx E; Caers J; Delaunois S; Delforge M; Deneve D; Kint N; Meuleman N; Sarrazyn L; Schots R; Vanhellemont A; Vekemans MC (Annals of hematology, 2026)